Skip to content
Certified ManufacturersFor manufacturers

GMP Laboratories of America, Inc.

Anaheim, CA, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

GMP Laboratories of America, Inc. is a dietary supplement manufacturer in Anaheim, CA, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, gummies, liquids, oils, powders and tablets.

Facilities listed
2
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Products on its USDA Organic certificate

Product types among the organic items that GMP Laboratories of America, Inc.’s certified operation lists in the USDA Organic Integrity Database.

USDA Organic Integrity Database, operation 5350000083, checked .

These are organic items only: the certificate says nothing about the company’s non-organic products. A listed item is the certifier’s record of what the operation is certified to handle organically, not a test of the product. About USDA Organic item lists

Certified facilities

Manufacturing (2)

  • 1240 North Red Gum Street, Anaheim, CA 92806, United States

    • Coating
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Warehousing
  • 2931 East La Jolla Street, Anaheim, CA 92806, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How GMP Laboratories of America, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

FDA lists 2 recalls matching the name GMP Laboratories of America, Inc., as of .

  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.

    2 products, first listed: Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X0…

    See all 2 products
    • Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9
    • Lithium Orotate, Weyland Brain Nutrition ; 60 vegetarian capsules, Dietary Supplement; Distributed by Enjoy Nutirtion, LLC. San Francisco, CA 94108, (415) 894-0537 2.5 mg UPC#: X001SBI13J 5 mg UPC#: X000PY16Z5 10 mg UPC#: X000T9B9B7 20 mg UPC#: X001VBLW8H 1000 MCG UPC#: X003SBV661
    openFDA record
  • Class II · Could cause temporary or reversible health problems

    Reported

    Closed by FDA

    The firm recalled because the product lot contained mispackaged product wherein some capsules were missing from the finished packaged product.

    Product: Dietary supplement. Product is labeled as :" Rescue Me***911 Damage Control***brantley living herbal formulas***HERBAL SUPPLEMENT 15 INDIVIDUAL PACKETS 4 VEGAN…

    Full product description
    • Dietary supplement. Product is labeled as :" Rescue Me***911 Damage Control***brantley living herbal formulas***HERBAL SUPPLEMENT 15 INDIVIDUAL PACKETS 4 VEGAN CAPSULES PER PACKET (2-368mg/2-584mg Each)***DISTRIBUTED EXCLUSIVELY BY: Living Herbal Pharmacy, LLC PO Box 56-2410, Miami, FL 33256-2410***".
    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 5 food or dietary supplement inspections at facilities matching GMP Laboratories of America, Inc., from 2010 to 2024, as of . 1 found no objectionable conditions and 4 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Anaheim, California

    4 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
    • Master manufacturing record - record requirements (21 CFR 111.210)
    Full citation text
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength and composition.

    • Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))

      You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    FEI 3010532947

  • No action indicated · No objectionable conditions found

    Inspected

    Anaheim, California

    FEI 3002710875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Anaheim, California

    9 citations posted:

    • Physical plant - separate areas - holding (21 CFR 111.20(c)(7))
    • Physical plant - design and construction (21 CFR 111.20(d))
    • Quality control - quality, dietary supplement (21 CFR 111.65)
    • Laboratory methodology followed (21 CFR 111.325(b)(2))
    See all 9 citations
    • Physical plant - separate areas - holding (21 CFR 111.20(c)(7))

      You did not use separate or defined areas of adequate size or other control systems prevent contamination or mix-ups of components or dietary supplements during holding operations.

    • Physical plant - design and construction (21 CFR 111.20(d))

      Your physical plant was not designed and constructed in a manner that prevents contamination of components, dietary supplements, or contact surfaces.

    • Quality control - quality, dietary supplement (21 CFR 111.65)

      You did not implement quality control operations to ensure the quality of the dietary supplement.

    • Laboratory methodology followed (21 CFR 111.325(b)(2))

      You did not make and keep documentation that established laboratory methodology was followed.

    • Defined areas of adequate size for operations (21 CFR 211.42(c))

      The separate or defined areas necessary to prevent contamination or mix-ups are deficient.

    • Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))

      Equipment and utensils are not cleaned and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

    • Scientifically sound laboratory controls (21 CFR 211.160(b))

      Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that components and drug products conform to appropriate standards of identity, strength, quality and purity.

    • Records reviewed annually (21 CFR 211.180(e))

      Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need for changes in specifications or manufacturing or control procedures.

    • Complete test data included in records (21 CFR 211.194(a))

      Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

    FEI 3002710875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Anaheim, California

    11 citations posted:

    • Hand-washing facilities (21 CFR 111.15(i))
    • Hold - temperature, humidity, light (21 CFR 111.455(a))
    • Written procedures - product complaint (21 CFR 111.553)
    • Product complaint -investigate, findings, follow-up (21 CFR 111.560(c))
    See all 11 citations
    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities do not furnish running water at a suitable temperature.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • Written procedures - product complaint (21 CFR 111.553)

      You did not follow written procedures for the requirements to review and investigate a product complaint.

    • Product complaint -investigate, findings, follow-up (21 CFR 111.560(c))

      Your review about whether to investigate a product complaint and findings and follow-up action of an investigation performed did not extend to all relevant batches and records.

    • GMP Training Frequency (21 CFR 211.25(a))

      GMP training is not conducted on a continuing basis and with sufficient frequency to assure that employees remain familiar with CGMP requirements applicable to them.

    • Washing and toilet facilities are deficient (21 CFR 211.52)

      Washing and toilet facilities lack hot and cold water.

    • Equipment Design, Size and Location (21 CFR 211.63)

      Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use and cleaning and maintenance.

    • Written procedures not established/followed (21 CFR 211.67(b))

      Written procedures are not followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.

    • Storage under appropriate conditions (21 CFR 211.142(b))

      Drug products are not stored under appropriate conditions of temperature and humidity so that their identity, strength, quality, and purity are not affected.

    • Records reviewed annually (21 CFR 211.180(e))

      Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need for changes in specifications or manufacturing or control procedures.

    • Identification of Person Performing Review of Lab Records (21 CFR 211.194(a)(8))

      Laboratory records are deficient in that they do not include the initials and signature of the second person reviewing the record for accuracy.

    FEI 3002710875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Anaheim, California

    17 citations posted:

    • Water supply - not component - suitability (21 CFR 111.15(e)(1))
    • Plumbing - backflow, cross connection (21 CFR 111.15(f)(5))
    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
    • Quality control - basis; tests, examinations (21 CFR 111.105(d))
    See all 17 citations
    • Water supply - not component - suitability (21 CFR 111.15(e)(1))

      Water that does not become a component of the dietary supplement was not at suitable temperature for all uses.

    • Plumbing - backflow, cross connection (21 CFR 111.15(f)(5))

      The plumbing in your physical plant allows backflow from piping systems that discharge waste water or sewage and piping systems that carry water used for manufacturing dietary supplements, for cleaning contact surfaces, or for use in bathrooms or hand-washing facilities.

    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))

      You did not maintain, clean, and sanitize equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.

    • Quality control - basis; tests, examinations (21 CFR 111.105(d))

      Your quality control personnel did not review and approve the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification will ensure that the finished batch of the dietary supplement meets product specifications.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • GMP Training Frequency (21 CFR 211.25(a))

      GMP training is not conducted on a continuing basis and with sufficient frequency to assure that employees remain familiar with CGMP requirements applicable to them.

    • Sanitation--buildings not clean, free of infestation (21 CFR 211.56(a))

      Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition.

    • Equipment Design, Size and Location (21 CFR 211.63)

      Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design, of adequate size, and suitably located to facilitate operations for its intended use and cleaning and maintenance.

    • Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))

      Equipment and utensils are not cleaned and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

    • Approval and review of procedures (21 CFR 211.100(a))

      Written procedures are not reviewed and approved by the quality control unit.

    • Component release checked by 2nd person (21 CFR 211.101(d))

      Each container of component dispensed to manufacturing is not examined by a second person to assure that the component was released by the quality control unit and the weight or measure is correct as stated in the batch records.

    • Control procedures to monitor and validate performance (21 CFR 211.110(a))

      Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.

    • Microbiological testing (21 CFR 211.165(b))

      Each batch of drug product required to be free of objectionable microorganisms is not tested through appropriate laboratory testing.

    • Items to cover on annual reviews (21 CFR 211.180(e)(2))

      Written procedures are not followed for evaluations done at least annually and including provisions for a review of complaints, recalls, returned or salvaged drug products, and investigations conducted for each drug product.

    • Identification of Equipment and Lines (21 CFR 211.188(b)(2))

      The batch production and control records are deficient in that they do not include the identity of major equipment used.

    • No written record of investigation (21 CFR 211.192)

      Written records are not always made of investigations into unexplained discrepancies and the failure of a batch or any of its components to meet specifications.

    • Second person sign off (21 CFR 211.194(a)(8))

      Laboratory records do not include the initials or signature of a second person showing that the original records have been reviewed for accuracy, completeness, and compliance with established standards.

    FEI 3002710875

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What GMP Laboratories of America, Inc. says it offers

From GMP Laboratories of America, Inc.’s own website, checked . Not verified by us.

Products

  • Vitamins & mineralsShow quote“has played a key role in establishing GMP Laboratories as a leading contract manufacturer of high quality vitamins and nutritional supplements.”
    “has played a key role in establishing GMP Laboratories as a leading contract manufacturer of high quality vitamins and nutritional supplements.”

    Source page · seen on

  • Pet supplementsShow quote“GMP Labs maintains a Pet Food Processor License in order to manufacture pet supplement products in liquid, powder, wafer, and chew dosage forms.”
    “GMP Labs maintains a Pet Food Processor License in order to manufacture pet supplement products in liquid, powder, wafer, and chew dosage forms.”

    Source page · seen on

Services

  • Private labelShow quote“We have a product catalog that gives customers example formulas if they do not have a formula ready that they can choose and customize for their own brand.”
    “We have a product catalog that gives customers example formulas if they do not have a formula ready that they can choose and customize for their own brand.”

    Source page · seen on

  • Custom formulationShow quote“At GMP Labs our Research and Development (R&D) Department will help bring your concepts to reality.”
    “At GMP Labs our Research and Development (R&D) Department will help bring your concepts to reality.”

    Source page · seen on

  • Contract manufacturingShow quote“GMP Laboratories of America is a custom contract manufacturer of quality dietary supplements and homeopathic drug products.”
    “GMP Laboratories of America is a custom contract manufacturer of quality dietary supplements and homeopathic drug products.”

    Source page · seen on

  • TurnkeyShow quote“We specialize in turnkey service, which means that we supply everything (ingredients and packaging components) when we manufacture and package the product to your specifications.”
    “We specialize in turnkey service, which means that we supply everything (ingredients and packaging components) when we manufacture and package the product to your specifications.”

    Source page · seen on

  • Packaging & bottlingShow quote“This service fits many of our clients who need capsules or powder supplements packaged in bottles.”
    “This service fits many of our clients who need capsules or powder supplements packaged in bottles.”

    Source page · seen on

Product certifications it claims

  • KosherShow quote“Kosher and Halal Certification Services are available upon request.”
    “Kosher and Halal Certification Services are available upon request.”

    Source page · seen on

  • HalalShow quote“Kosher and Halal Certification Services are available upon request.”
    “Kosher and Halal Certification Services are available upon request.”

    Source page · seen on

  • Organic productsShow quote“Please contact one of our sales managers if you are interested in having your product organic certified.”
    “Please contact one of our sales managers if you are interested in having your product organic certified.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from public registry listings

Last checked

  • NSF/ANSI 455-2 GMP certification
  • USDA Organic certified operation
  • 2 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility
  • Product types on its USDA Organic certificate (organic items only)

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other gummy manufacturers in the United States

  1. NSF lists 4 gummy facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a gummy facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists 2 gummy facilities, including one in St. Augustine, FL

    St. Augustine, FL, United Statesactivegummy.com

    • Gummies
    Operations:
    • Molding
    • Coating
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a gummy facility in Merrilville, IN

    Merrilville, IN, United Statesalbanesecandy.com

    • Gummies
    Operations:
    • Molding
    • Liquid formulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists a gummy facility in Miami, FL

    Miami, FL, United Statesalfavitamins.com

    • Capsules
    • Gummies
    • Liquids
    • Softgels
    • Tablets
    Operations:
    • Pasteurization
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a gummy facility in Dallas, TX

    Dallas, TX, United Statesforeverliving.com

    • Gummies
    • Liquids
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026